GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 209 filers reported holding GENMAB A/S in Q2 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $845,563 | -8.9% | 23,974 | -1.9% | 0.03% | +8.0% |
| Q2 2023 | $928,434 | -1.8% | 24,426 | -2.5% | 0.02% | 0.0% |
| Q1 2023 | $945,776 | +11.7% | 25,047 | +25.3% | 0.02% | -78.3% |
| Q4 2022 | $846,880 | +35.1% | 19,983 | +2.3% | 0.12% | +26.4% |
| Q3 2022 | $627,000 | +7.2% | 19,525 | +8.4% | 0.09% | +19.7% |
| Q2 2022 | $585,000 | -5.0% | 18,015 | +5.9% | 0.08% | 0.0% |
| Q1 2022 | $616,000 | -46.6% | 17,015 | -41.7% | 0.08% | -41.1% |
| Q4 2021 | $1,154,000 | +107.9% | 29,186 | +129.9% | 0.13% | +51.8% |
| Q3 2021 | $555,000 | +25.9% | 12,697 | +17.5% | 0.08% | -2.3% |
| Q2 2021 | $441,000 | +45.1% | 10,802 | +16.8% | 0.09% | +29.9% |
| Q1 2021 | $304,000 | – | 9,247 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 242,848 | $9,169,940 | 3.80% |
| Capricorn Fund Managers Ltd | 110,643 | $4,177,880 | 1.28% |
| Arlington Capital Management, Inc. | 35,591 | $1,343,916 | 1.26% |
| XY Capital Ltd | 76,884 | $2,903,140 | 1.13% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 88,000 | $3,322,880 | 0.93% |
| TORRAY INVESTMENT PARTNERS LLC | 110,807 | $4,184,072 | 0.75% |
| Hardman Johnston Global Advisors LLC | 585,139 | $22,094,849 | 0.72% |
| Yorktown Management & Research Co Inc | 16,600 | $626,816 | 0.68% |
| First Light Asset Management, LLC | 160,025 | $6,042,544 | 0.54% |
| MIRABELLA FINANCIAL SERVICES LLP | 28,260 | $2,505,855 | 0.38% |